Mario Occhipinti

Mario Occhipinti

Università degli Studi di Roma La Sapienza - Rome / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1800929
Sapienza University of Rome
person_outline Mario Occhipinti's MOST POPULAR ARTICLES
1-) A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorableA Cortellini, M Bersanelli, S Buti, K Cannita, D Santini, F Perrone, R Giusti, ...Journal for immunotherapy of cancer 7 (1), 1-11, 20192322019
2-) Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practiceA Cortellini, M Tucci, V Adamo, LS Stucci, A Russo, ET Tanda, ...Journal for immunotherapy of cancer 8 (2), 20201452020
3-) KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burdenD Marinelli, M Mazzotta, S Scalera, I Terrenato, F Sperati, L D\\\'Ambrosio, ...Annals of Oncology 31 (12), 1746-1754, 20201422020
4-) Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective …A Russo, M Russano, T Franchina, MR Migliorino, G Aprile, G Mansueto, ...Advances in therapy 37, 1145-1155, 20201542020
5-) The sexist behaviour of immune checkpoint inhibitors in cancer therapy?A Botticelli, CE Onesti, I Zizzari, B Cerbelli, P Sciattella, M Occhipinti, ...Oncotarget 8 (59), 20171002017